Ted Love

Ted Love

Direttore/Membro del Consiglio presso GILEAD SCIENCES, INC.

Patrimonio netto: 4 M $ in data 31/05/2026

67 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Dr. Ted W.
Love
, MD, is an Independent Director at Gilead Sciences, Inc., an Independent Director at Structure Therapeutics, Inc. and a Lead Independent Director at Royalty Pharma Plc.
He is on the Board of Directors at Jazz Pharmaceuticals Plc, Gilead Sciences, Inc., Structure Therapeutics, Inc., Royalty Pharma Plc, Avillion LLP, Biotechnology Innovation Organization and Life Science Cares Bay Area.
Dr. Love was previously employed as an Independent Director by Seagen, Inc., an Independent Director by Portola Pharmaceuticals LLC, a President, Chief Executive Officer & Director by Global Blood Therapeutics, Inc., an Independent Director by CASCADIAN THERAPEUTICS INC, an Independent Director by Mast Therapeutics, Inc., an Independent Director by Amicus Therapeutics, Inc., an Independent Director by Bio-Rad Laboratories, Inc., an Executive VP, Head-Research & Development by Onyx Pharmaceuticals, Inc., a Lead Independent Director by KaloBios Pharmaceuticals, Inc., an Independent Director by Affymax, Inc., an Independent Director by Santarus, Inc., a Chairman, President & Chief Executive Officer by Nuvelo, Inc., a Senior Vice President-Development by Theravance, Inc., a Senior Vice President-Development by Theravance Biopharma Us LLC, and a VP-Product Development & Regulatory Affairs by Genentech, Inc. He also served on the board at Anesiva, Inc., ARCA biopharma, Inc., California Institute for Regenerative Medicine, ARCA biopharma, Inc. /Old/, California Healthcare Institute, Predix Pharmaceuticals, Inc., Stanford Health Care-Stanford Hospital and The Biotechnology Institute.
He received his undergraduate degree from Haverford College and a doctorate degree from Yale School of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
05/06/2026 58.393 ( 0,01% ) 3 M $ 31/05/2026
30/04/2026 5.484 ( 0% ) 737 214 $ 31/05/2026
25/05/2026 1.527 ( 0% ) 361 120 $ 31/05/2026
17/06/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Ted Love

SocietàPosizioneInizio
ROYALTY PHARMA PLC Direttore/Membro del Consiglio 30/07/2020
STRUCTURE THERAPEUTICS INC. Direttore/Membro del Consiglio 03/08/2023
GILEAD SCIENCES, INC. Direttore/Membro del Consiglio 01/02/2024
JAZZ PHARMACEUTICALS PLC Direttore/Membro del Consiglio 01/12/2025
Life Science Cares Bay Area
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/01/2025
Direttore/Membro del Consiglio 22/07/2013

Precedenti posizioni note di Ted Love

SocietàPosizioneFine
SEAGEN INC. Direttore/Membro del Consiglio 14/12/2023
GLOBAL BLOOD THERAPEUTICS, INC. Amministratore Delegato 05/10/2022
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Ted Love

Formazione di Ted Love

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

73

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Government

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Life Science Cares Bay Area

Commercial Services